{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T13:14:42Z","timestamp":1722777282424},"reference-count":46,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.jviromet.2010.05.012","type":"journal-article","created":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T12:29:25Z","timestamp":1274358565000},"page":"177-190","source":"Crossref","is-referenced-by-count":5,"title":["Mammalian expression of functional autologous red cell agglutination reagents for use in diagnostic assays"],"prefix":"10.1016","volume":"168","author":[{"given":"J.","family":"Hobson-Peters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Toye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2010.05.012_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1008170710003","article-title":"Advances in animal cell recombinant protein production: GS-NS0 expression system","volume":"32","author":"Barnes","year":"2000","journal-title":"Cytotechnology"},{"key":"10.1016\/j.jviromet.2010.05.012_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/bit.1059","article-title":"Characterization of the stability of recombinant protein production in the GS-NS0 expression system","volume":"73","author":"Barnes","year":"2001","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jviromet.2010.05.012_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/bit.21119","article-title":"Molecular analysis of successful cell line selection in transfected GS-NS0 myeloma cells","volume":"96","author":"Barnes","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jviromet.2010.05.012_bib4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/bit.20856","article-title":"Phenotypic variation during cloning procedures: analysis of the growth behavior of clonal cell lines","volume":"94","author":"Barnes","year":"2006","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jviromet.2010.05.012_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nbt0292-169","article-title":"High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker","volume":"10","author":"Bebbington","year":"1992","journal-title":"Biotechnology (N. Y.)"},{"key":"10.1016\/j.jviromet.2010.05.012_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1021\/bp00025a011","article-title":"Monoclonal antibody process development using medium concentrates","volume":"10","author":"Bibila","year":"1994","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jviromet.2010.05.012_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/108497803322285099","article-title":"Chimeric TNT-3\/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT)","volume":"18","author":"Biela","year":"2003","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.jviromet.2010.05.012_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02521750","article-title":"Process development for the production of recombinant antibodies using the glutamine synthetase (GS) system","volume":"9","author":"Brown","year":"1992","journal-title":"Cytotechnology"},{"key":"10.1016\/j.jviromet.2010.05.012_bib9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-2427(85)90084-4","article-title":"Monoclonal antibodies directed against Brucella abortus cell surface antigens","volume":"8","author":"Bundesen","year":"1985","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.jviromet.2010.05.012_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pep.2003.12.008","article-title":"Cloning, expression, and characterization of single-chain variable fragment antibody against mycotoxin deoxynivalenol in recombinant Escherichia coli","volume":"35","author":"Choi","year":"2004","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jviromet.2010.05.012_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0958-1669(00)00197-X","article-title":"Industrial choices for protein production by large-scale cell culture","volume":"12","author":"Chu","year":"2001","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jviromet.2010.05.012_bib12","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1098\/rstb.2001.0889","article-title":"Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence","volume":"356","author":"Cleaveland","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B: Biol. Sci."},{"key":"10.1016\/j.jviromet.2010.05.012_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0022-1759(95)00264-2","article-title":"Construction of recombinant extended single-chain antibody peptide conjugates for use in the diagnosis of HIV-1 and HIV-2","volume":"192","author":"Coia","year":"1996","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2010.05.012_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0049-3848(03)00152-X","article-title":"Generation and characterization of recombinant single chain Fv antibody that recognizes platelet glycoprotein Ibalpha","volume":"109","author":"Dai","year":"2003","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jviromet.2010.05.012_bib15","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2010.05.012_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/1380-2933(95)00021-6","article-title":"Escherichia coli expression of a bifunctional Fab-peptide epitope reagent for the rapid diagnosis of HIV-1 and HIV-2","volume":"1","author":"Dolezal","year":"1995","journal-title":"Immunotechnology"},{"key":"10.1016\/j.jviromet.2010.05.012_bib17","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nbt0994-890","article-title":"Mammalian cell expression of single-chain Fv (sFv) antibody proteins and their C-terminal fusions with interleukin-2 and other effector domains","volume":"12","author":"Dorai","year":"1994","journal-title":"Biotechnology (N. Y.)"},{"key":"10.1016\/j.jviromet.2010.05.012_bib18","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1128\/AEM.66.11.5024-5029.2000","article-title":"Specific secretion of active single-chain Fv antibodies into the supernatants of Escherichia coli cultures by use of the hemolysin system","volume":"66","author":"Fernandez","year":"2000","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.jviromet.2010.05.012_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-1656(99)00183-2","article-title":"Very high expression of an anti-carcinoembryonic antigen single chain Fv antibody fragment in the yeast Pichia pastoris","volume":"76","author":"Freyre","year":"2000","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jviromet.2010.05.012_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00262-002-0302-6","article-title":"Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer","volume":"51","author":"Gillies","year":"2002","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jviromet.2010.05.012_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1046-5928(02)00532-6","article-title":"Expression, purification, and characterization of an anti-RBCFab-p24 fusion protein for hemagglutination-based rapid detection of antibodies to HIV in whole blood","volume":"26","author":"Gupta","year":"2002","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jviromet.2010.05.012_bib22","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1128\/JCM.41.7.2814-2821.2003","article-title":"Whole-blood agglutination assay for on-site detection of human immunodeficiency virus infection","volume":"41","author":"Gupta","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jviromet.2010.05.012_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1472-6750-6-39","article-title":"Bifunctional recombinant fusion proteins for rapid detection of antibodies to both HIV-1 and HIV-2 in whole blood","volume":"6","author":"Gupta","year":"2006","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.jviromet.2010.05.012_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-1759(01)00435-5","article-title":"Recombinant fusion proteins for haemagglutination-based rapid detection of antibodies to HIV in whole blood","volume":"256","author":"Gupta","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2010.05.012_bib25","first-page":"52","article-title":"Disease diagnosis in two minutes","volume":"3","author":"Hillyard","year":"1991","journal-title":"Todays Life Sci."},{"key":"10.1016\/j.jviromet.2010.05.012_bib26","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1099\/vir.0.2008\/003731-0","article-title":"A glycosylated peptide in the West Nile virus envelope protein is immunogenic during equine infection","volume":"89","author":"Hobson-Peters","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2010.05.012_bib27","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2144\/02326st03","article-title":"High-level expression of recombinant Fc chimeric proteins in suspension cultures of stably transfected J558L cells","volume":"32","author":"Howard","year":"2002","journal-title":"Biotechniques"},{"key":"10.1016\/j.jviromet.2010.05.012_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0049-3848(90)90097-V","article-title":"The simpliRED D dimer test: a novel assay for the detection of crosslinked fibrin degradation products in whole blood","volume":"58","author":"John","year":"1990","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jviromet.2010.05.012_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00767768","article-title":"The use of serum-free medium for the production of functionally active humanised monoclonal antibody from NS0 mouse myeloma cells engineered using glutamine synthetase as a selectable marker","volume":"18","author":"Keen","year":"1996","journal-title":"Cytotechnology"},{"key":"10.1016\/j.jviromet.2010.05.012_bib30","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.3413497","article-title":"Autologous red cell agglutination assay for HIV-1 antibodies: simplified test with whole blood","volume":"241","author":"Kemp","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2010.05.012_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0022-1759(96)00093-2","article-title":"High-level expression in insect cells and purification of secreted monomeric single-chain Fv antibodies","volume":"195","author":"Kretzschmar","year":"1996","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2010.05.012_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90041-8","article-title":"Recombinant single-chain antibody peptide conjugates expressed in Escherichia coli for the rapid diagnosis of HIV","volume":"171","author":"Lilley","year":"1994","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2010.05.012_bib33","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s00259-005-0025-y","article-title":"Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6\/22-80B3 Fab\u2019","volume":"33","author":"Macfarlane","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jviromet.2010.05.012_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1128\/IAI.01494-06","article-title":"Identification of a glycosylated Ehrlichia canis 19-kilodalton major immunoreactive protein with a species-specific serine-rich glycopeptide epitope","volume":"75","author":"McBride","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jviromet.2010.05.012_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0378-1119(95)00638-9","article-title":"A COS-cell-based system for rapid production and quantification of scFv::IgC kappa antibody fragments","volume":"166","author":"Ridder","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.jviromet.2010.05.012_bib36","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/bit.260440609","article-title":"Characterization of a recombinant antibody produced in the course of a high yield fed-batch process","volume":"44","author":"Robinson","year":"1994","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jviromet.2010.05.012_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5694\/j.1326-5377.1990.tb124459.x","article-title":"A rapid whole-blood immunoassay system","volume":"152","author":"Rylatt","year":"1990","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.jviromet.2010.05.012_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-1656(99)00036-X","article-title":"High cytoplasmic expression in E. coli, purification, and in vitro refolding of a single chain Fv antibody fragment against the hepatitis B surface antigen","volume":"72","author":"Sanchez","year":"1999","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jviromet.2010.05.012_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2005.02.020","article-title":"Characterization of neutralizing antibodies to West Nile virus","volume":"336","author":"Sanchez","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2010.05.012_bib40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/bp049780w","article-title":"On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells","volume":"21","author":"Schlatter","year":"2005","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jviromet.2010.05.012_bib41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/153685902321043954","article-title":"Generation of human interferon gamma and tumor Necrosis factor alpha chimeric TNT-3 fusion proteins","volume":"21","author":"Sharifi","year":"2002","journal-title":"Hybrid. Hybridomics"},{"key":"10.1016\/j.jviromet.2010.05.012_bib42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/prep.2001.1521","article-title":"Production of an anti-prostate-specific antigen single-chain antibody fragment from Pichia pastoris","volume":"23","author":"Wang","year":"2001","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jviromet.2010.05.012_bib43","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1146\/annurev.cb.06.110190.003335","article-title":"Position effects on eukaryotic gene expression","volume":"6","author":"Wilson","year":"1990","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.jviromet.2010.05.012_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-1759(91)90070-V","article-title":"Rapid whole blood assay for HIV-1 seropositivity using an Fab-peptide conjugate","volume":"138","author":"Wilson","year":"1991","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jviromet.2010.05.012_bib45","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/nbt1026","article-title":"Production of recombinant protein therapeutics in cultivated mammalian cells","volume":"22","author":"Wurm","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jviromet.2010.05.012_bib46","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/(SICI)1097-0290(19970905)55:5<783::AID-BIT8>3.0.CO;2-7","article-title":"Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production","volume":"55","author":"Zhou","year":"1997","journal-title":"Biotechnol. Bioeng."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093410001953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093410001953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T21:56:16Z","timestamp":1591307776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093410001953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":46,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0166093410001953"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2010.05.012","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}